...
首页> 外文期刊>Molecular cancer therapeutics >Oleanolic Acid Inhibits Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Promoting iNOS Dimerization
【24h】

Oleanolic Acid Inhibits Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Promoting iNOS Dimerization

机译:通过促进Inos二聚化,烯醇酸抑制肝细胞癌的上皮 - 间充质转变

获取原文
获取原文并翻译 | 示例
           

摘要

Oleanolic acid exhibits extensive pharmacologic activities and takes significant antitumor effects. Its pharmacologic mechanism, however, still remained to be further clarified. In this study, we demonstrated that oleanolic acid attenuated the migration and invasion abilities, resulting in the suppression of the epithelial-mesenchymal transition (EMT) process in liver cancer cells, and inhibited the tumor growth of the peritoneal lymphocytes-bearing mice. We further proved that inducible nitric oxide synthase (iNOS) may be the potential target of oleanolic acid. We confirmed that oleanolic acid could pro-mote the dimerization of iNOS, activating it, and subsequently increasing the production of nitric oxide. Further experiments indicated that oleanolic acid promoted the nitration of specific proteins and consequently suppressed their EMT-related biological functions. Furthermore, it has been confirmed that oleanolic acid enhanced the antitumor effects of regorafenib in liver cancer treatment. These results deepened our understanding of the pharmacologic mechanism of the antitumor effect oleanolic acid, and the importance of nitric oxide synthetase as a therapeutic target for liver cancer treatment.
机译:甲醛酸表现出广泛的药理学活动,并采取显着的抗肿瘤作用。然而,其药理学机制仍然保持进一步澄清。在这项研究中,我们证明奥沙尔醇酸衰减迁移和侵袭能力,导致抑制肝癌细胞中的上皮 - 间充质转换(EMT)过程,并抑制患有腹膜淋巴细胞的小鼠的肿瘤生长。我们进一步证明了可诱导的一氧化氮合酶(InOS)可以是烯醇酸的潜在靶标。我们证实,OLEALIC酸可以促进INOS的二聚化,激活它,随后增加一氧化氮的产生。进一步的实验表明,OleAlic酸促进了特异性蛋白质的硝化,因此抑制了其相关的EMT相关的生物学功能。此外,已经证实,OLEALIC酸增强了肝癌治疗中的Regorafenib的抗肿瘤作用。这些结果深化了我们对抗肿瘤作用奥沙尔酸的药理机制的理解,以及一氧化氮合成酶作为肝癌治疗治疗靶标的重要性。

著录项

  • 来源
    《Molecular cancer therapeutics》 |2019年第1期|共13页
  • 作者单位

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Hosp Shun Yi Dist Dept Pathol Beijing Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号